Avi Schroeder is an associate professor and a member of the Wolfson Faculty of Chemical Engineering at the Technion. He leads the Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies.
Prof. Schroeder’s focus is on the development of targeted and more personalized medicines, including nanotechnology. Of particular focus to him is using such medicines to better and more effectively treat cancer and improve patients’ quality of life. He is the author of scientific papers in the field of nanotechnology and medicine and is the inventor on 14 patents.
Prof. Schroeder has received 20 national and international innovation awards and is a successful scientific entrepreneur, having launched five Technion spin offs.